Navigation Links
FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
Date:9/14/2007

sal phase of their lives, the incidence of certain diseases, such as invasive breast cancer and osteoporosis, increases dramatically," said Steven Cummings, M.D., emeritus professor of medicine and epidemiology and biostatistics at the University of California San Francisco. "Therefore, it's important for postmenopausal women to be aware of these serious risks and have treatment choices to address them."

The FDA evaluated a data package that included multiple trials assessing three different populations of postmenopausal women:

-- The Study of Tamoxifen and Raloxifene (STAR) trial, sponsored by the National Cancer Institute (NCI) and coordinated by the National Surgical Adjuvant Breast and Bowel Project (NSABP), involved postmenopausal women at increased risk for invasive breast cancer. The observed incidence rates of invasive breast cancer were EVISTA 4.4 and tamoxifen 4.3, per 1000 women per year.

-- The Raloxifene Use for The Heart (RUTH) trial looked at postmenopausal women with known or at increased risk for coronary disease. The study demonstrated that EVISTA significantly reduced the risk of invasive breast cancer in postmenopausal women by 44 percent with an absolute risk reduction of 0.6 percent.

-- The Multiple Outcomes of Raloxifene Evaluation (MORE) and Continuing Outcomes Relevant to Evista (CORE) trials evaluated postmenopausal women with osteoporosis. Both four-year trials showed that EVISTA reduced the risk of invasive breast cancer in women by 71 percent with an absolute risk reduction of 1.1 percent, and 56 percent with an absolute risk reduction of 1.0 percent, respectively.

Important Safety Information About EVISTA(R)

EVISTA is not for everyone. If you are or still can become pregnant, are nursing, or have had blood clots that required a doctor's treatment, you cannot take EVISTA. An infrequent but serious side effect of EVISTA is blood clots in the veins - being immobile for a long time may add to the risk.'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA approves MyocondaR IND for MAP in Crohns Disease
2. FDA approves IND on Lead Product M6G
3. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
4. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
5. Once-yearly Reclast Significantly Reduced Bone Fractures in Women with Postmenopausal Osteoporosis
6. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
7. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
8. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
11. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 Marken announced today the expansion ... meet the clinical trial logistics growth in Central and ... facility will continue to serve as a regional center ... from the region, and will provide additional storage capacity. ... combine its office and warehouse into a single facility, ...
(Date:7/30/2014)... July 30, 2014  There is still time ... success. The 10th Annual Institute for Supply Management ... Excellence in Supply Management is open for submissions.  ... understanding and importance of supply management by recognizing ... best supply management practices.  Entries are due August ...
(Date:7/30/2014)... 2014 In conjunction with DURECT Corporation,s (Nasdaq: ... press release, you are invited to listen to the ... internet on Thursday, August 7, 2014 at 4:30 pm ... live audio webcast of the presentation will be available ... clicking "Investor Relations."  If you are unable to participate ...
Breaking Medicine Technology:Marken Expands Miami Regional Logistics Center 2Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call 2
... May 4, 2012 Medical device and medical ... their products meet quality standards and regulations at ... and product development to manufacturing and post-marketing activity. ... an increasingly competitive marketplace, medical device organizations are ...
... PARSIPPANY, N.J., May 4, 2012  Watson Pharmaceuticals, Inc. (NYSE: ... DeFrancesco has been promoted to the position of Vice ... Ms. DeFrancesco reports to Charles Mayr, Chief Communications Officer ... Watson on June 1, 2012. In this ...
Cached Medicine Technology:Staffing and Performance Benchmarks for Quality Function Highlight New Medical Device Study 2Watson Names Lisa DeFrancesco Vice President, Global Investor Relations 2
(Date:7/31/2014)... Beverly Hills, CA (PRWEB) July 31, 2014 ... president George W. Bush recently underwent partial knee replacement surgery ... right knee less than two months earlier. The story also ... between the procedures and hopes to be back on the ... replacement surgery highlights the benefits of partial knee replacement. ...
(Date:7/31/2014)... 31, 2014 ProtonPACS, a division of ... the National Rural Health Association (NRHA), company officials announced ... understanding the needs of rural health providers nationwide. , ... Health Association,” said Dr. Mark Awh, President of Radsource. ... of ProtonPACS, we are also looking forward to learning ...
(Date:7/31/2014)... 2014) While it is known that members of the ... a new study finds that female enlistees and female ... civilian counterparts. This study was published today in ... on behalf of the Inter-University Seminar on Armed Forces ... Tedrow studied surveys of nearly 9,000 men and women ...
(Date:7/31/2014)... Staying happy in a relationship and loving for years ... get sucked into the logistical ruts they know as their ... kids. , That’s why Couples in Trouble Relationship Expert, ... to Reignite the Spark in Your Marriage TODAY” Guide as ... much better path to happiness, and a far less costly ...
(Date:7/31/2014)... 2014 According to new research ... Mycoprotein), by Type (Tofu, Tofu-Based Product, Tempeh, TVP, ... Global Trends & Forecasts to 2019", defines and ... analysis and forecasting of the market value of ... report also identifies the driving and restraining factors ...
Breaking Medicine News(10 mins):Health News:George W. Bush’s Surgery Highlights the Benefits of Partial Knee Replacement 2Health News:ProtonPACS Announces Pipeline Partnership with the National Rural Health Association. 2Health News:Women in military less likely to drink than civilian women 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 2Health News:Couples in Trouble Relationship Expert, Dr. Jackie Black, Offers a Gift Guide to Reignite the Spark So Lovers Can Kiss-And-Make-Up 3Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 2Health News:Meat Substitutes Market Worth $4,622.4 Million by 2019 - New Report by MarketsandMarkets 3
... RESULTS, EUR,000,000 2008 ... 92.5 99.3 EBITDA* ... 14.0% 16.1% Current operating income* ... (2.8) (2.7) Net income ...
... central nervous system , , WEDNESDAY, July 30 (HealthDay News) ... depression, at least in mice. , According to the ... Istvan Mody, both of the David Geffen School of ... of a particular class of proteins called GABA receptors ...
... Data from 260 hospitals across the United States has ... to more accurately determine the severity of heart failure in ... mortality and more quickly identifying triage methods and treatment decisions. ... the Journal of the American College of Cardiology . ...
... for Universal, Health Coverage Proposal but Obstacles Remain, According ... ... 30 ,HealthLeaders-InterStudy, a leading provider of managed care market,intelligence, reports ... windfall for the state of New Mexico has resulted in ...
... recently,submitted its bid to the U.S. Department of ... third generation TRICARE South Region contract. If,awarded the ... active,duty, retired and participating reserve and National Guard ... on April 1, 2010., "It is TriServ,s ...
... Sunrise Senior Living,Inc. (NYSE: SRZ ) today ... and webcast to discuss the Company,s 2007 financial ... data.,The call will now be held on Friday, ... will issue its 2007 financial results and second-quarter ...
Cached Medicine News:Health News:PCAS : Half Result 2008 2Health News:Possible Cause of Postpartum Depression Pinpointed 2Health News:Possible Cause of Postpartum Depression Pinpointed 3Health News:New method assesses risks for heart failure patients 2Health News:Gov. Richardson's Healthcare Reform Agenda Gains New Life 2Health News:Sunrise Updates Date and Time of Conference Call to Discuss 2007 Financial Results and Second-Quarter 2008 Preliminary Selected Financial and Operating Data 2
Solid 14 mm blades. Dull finish....
Angled for temporal approach. Open 14 mm rounded blades for patient comfort. Dull finish....
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model....
Open wire style blades allow complete manipulation of the phaco tip inside the eye. Lid control is excellent, exposure is maximized, and the likelihood of positive pressure is reduced....
Medicine Products: